Literature DB >> 27094570

The role of global and regional gray matter volume decrease in multiple sclerosis.

Matthias Grothe1, Martin Lotze2, Sönke Langner3, Alexander Dressel4.   

Abstract

Disability in multiple sclerosis (MS) patients is associated with white matter (WM) and gray matter (GM) pathology, and both processes contribute differently over the disease course. Total and regional GM volume loss can be imaged via voxel-based morphometry (VBM). Here, we retrospectively analyzed a group of 213 MS patients [163 relapsing remitting (RR) and 50 secondary progressive (SP)] using semi-automated white matter (WM) lesion mapping and voxel-based morphometry (VBM). Our aim was to assess the association of increasing disability with decreasing total and regional GM volume. As expected, total GM volume and WM lesion load were associated with patients disability, measured with the Expanded Disability Status Scale (EDSS). The more impaired the patients, the greater the statistical association to the total GM volume. Regional volume loss in the cerebellar gray matter was associated with increasing EDSS and WM lesion volume. Furthermore, SPMS patients had significantly more gray matter volume loss in the cerebellum and the hippocampus compared to RRMS patients. Our results confirm histopathological studies emphasizing the important role of the cerebellum and the hippocampus in MS patients' disability.

Entities:  

Keywords:  EDSS; Gray matter atrophy; Multiple sclerosis; Voxel-based morphometry

Mesh:

Year:  2016        PMID: 27094570     DOI: 10.1007/s00415-016-8114-3

Source DB:  PubMed          Journal:  J Neurol        ISSN: 0340-5354            Impact factor:   4.849


  35 in total

Review 1.  Mechanisms of neuronal dysfunction and degeneration in multiple sclerosis.

Authors:  Ranjan Dutta; Bruce D Trapp
Journal:  Prog Neurobiol       Date:  2010-10-12       Impact factor: 11.685

2.  Structural covariance in the human cortex.

Authors:  Andrea Mechelli; Karl J Friston; Richard S Frackowiak; Cathy J Price
Journal:  J Neurosci       Date:  2005-09-07       Impact factor: 6.167

3.  Mapping regional grey and white matter atrophy in relapsing-remitting multiple sclerosis.

Authors:  Gianna Riccitelli; Maria A Rocca; Elisabetta Pagani; Vittorio Martinelli; Marta Radaelli; Andrea Falini; Giancarlo Comi; Massimo Filippi
Journal:  Mult Scler       Date:  2012-03-15       Impact factor: 6.312

4.  Brain atrophy in relapsing-remitting multiple sclerosis and secondary progressive multiple sclerosis: longitudinal quantitative analysis.

Authors:  Y Ge; R I Grossman; J K Udupa; L Wei; L J Mannon; M Polansky; D L Kolson
Journal:  Radiology       Date:  2000-03       Impact factor: 11.105

5.  A voxel-based morphometry study of disease severity correlates in relapsing-- remitting multiple sclerosis.

Authors:  A Prinster; M Quarantelli; R Lanzillo; G Orefice; G Vacca; B Carotenuto; B Alfano; A Brunetti; V Brescia Morra; M Salvatore
Journal:  Mult Scler       Date:  2009-12-22       Impact factor: 6.312

6.  Substantial archaeocortical atrophy and neuronal loss in multiple sclerosis.

Authors:  Dimitrios Papadopoulos; Sumayya Dukes; Ryan Patel; Richard Nicholas; Abhilash Vora; Richard Reynolds
Journal:  Brain Pathol       Date:  2008-05-20       Impact factor: 6.508

7.  Regional hippocampal atrophy in multiple sclerosis.

Authors:  N L Sicotte; K C Kern; B S Giesser; A Arshanapalli; A Schultz; M Montag; H Wang; S Y Bookheimer
Journal:  Brain       Date:  2008-04       Impact factor: 13.501

8.  Multiple sclerosis.

Authors:  Alastair Compston; Alasdair Coles
Journal:  Lancet       Date:  2008-10-25       Impact factor: 79.321

9.  MRI measures show significant cerebellar gray matter volume loss in multiple sclerosis and are associated with cerebellar dysfunction.

Authors:  V M Anderson; L K Fisniku; D R Altmann; A J Thompson; D H Miller
Journal:  Mult Scler       Date:  2009-05-22       Impact factor: 6.312

10.  Diagnostic criteria for multiple sclerosis: 2010 revisions to the McDonald criteria.

Authors:  Chris H Polman; Stephen C Reingold; Brenda Banwell; Michel Clanet; Jeffrey A Cohen; Massimo Filippi; Kazuo Fujihara; Eva Havrdova; Michael Hutchinson; Ludwig Kappos; Fred D Lublin; Xavier Montalban; Paul O'Connor; Magnhild Sandberg-Wollheim; Alan J Thompson; Emmanuelle Waubant; Brian Weinshenker; Jerry S Wolinsky
Journal:  Ann Neurol       Date:  2011-02       Impact factor: 10.422

View more
  4 in total

1.  Impairments in Walking Ability, Dexterity, and Cognitive Function in Multiple Sclerosis Are Associated with Different Regional Cerebellar Gray Matter Loss.

Authors:  Matthias Grothe; Martin Lotze; Sönke Langner; Alexander Dressel
Journal:  Cerebellum       Date:  2017-12       Impact factor: 3.847

2.  Baseline predictors of DMT reinitiation among patients with multiple sclerosis following an MI-CBT intervention.

Authors:  Joanie Thelen; Amanda Bruce; Delwyn Catley; Sharon Lynch; Kathy Goggin; Andrea Bradley-Ewing; Morgan Glusman; Abigail Norouzinia; Lauren Strober; Jared Bruce
Journal:  J Behav Med       Date:  2017-11-09

3.  'Timed up and go' and brain atrophy: a preliminary MRI study to assess functional mobility performance in multiple sclerosis.

Authors:  Lorena Lorefice; G Coghe; G Fenu; M Porta; G Pilloni; J Frau; F Corona; V Sechi; M A Barracciu; M G Marrosu; M Pau; E Cocco
Journal:  J Neurol       Date:  2017-09-11       Impact factor: 4.849

4.  The relationship between amplitude of low frequency fluctuations and gray matter volume of the mirror neuron system: Differences between low disability multiple sclerosis patients and healthy controls.

Authors:  Julio Plata-Bello; Yaiza Pérez-Martín; Abril Castañón-Pérez; Cristián Modroño; Estefanía Hernández-Martín; Montserrat González-Platas; Francisco Marcano; José Luis González-Mora
Journal:  IBRO Rep       Date:  2018-09-27
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.